Literature DB >> 6220973

Modification of macrophage phagocytosis in murine cryptococcosis.

M A Morgan, R A Blackstock, G S Bulmer, N K Hall.   

Abstract

Normal C57BL/6J peritoneal cells exhibited a decreased phagocytosis when cultured with a cell wall antigen of Cryptococcus sp. and lymphocytes from mice infected with C. neoformans. Direct cell-to-cell interaction was not required in that supernatant fluids from cultures of lymphocytes from infected animals could be incubated with normal macrophage monolayers to give comparable suppression. The induction of the suppressor factor required specific cryptococcal antigen; however, suppression at the macrophage level was nonspecific in that the phagocytosis of C. neoformans and Saccharomyces cerevisiae were both decreased. Suppression appeared with lymphocyte supernatants taken from mice infected for 14 days and thereafter. The factor was heat stable, trypsin sensitive, and allospecific.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220973      PMCID: PMC264882          DOI: 10.1128/iai.40.2.493-500.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. I. Suppression of contact sensitivity by soluble suppressor factor released in vitro by lymph node cell populations containing specific suppressor cells.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.

Authors:  R M Karaoui; N K Hall; H W Larsh
Journal:  Mykosen       Date:  1977-11

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice.

Authors:  M Zembala; G L Asherson
Journal:  Nature       Date:  1973-07-27       Impact factor: 49.962

5.  Regulation of delayed-type hypersensitivity. II. Specific suppressor factor for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  F Y Liew; W L Chan-Liew
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

6.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

7.  Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga.

Authors:  J B Neilson; M H Ivey; G S Bulmer
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

8.  Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.

Authors:  J W Murphy; J W Moorhead
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes.

Authors:  S S Rich; R R Rich
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  The I-J subregion codes for determinats on suppressor factor(s) which limit the contact sensitivity response to picryl chloride.

Authors:  M I Greene; A Pierres; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  12 in total

1.  Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Authors:  Rebecca Blackstock
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

2.  Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis.

Authors:  R Blackstock; N K Hall; N C Hernandez
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.

Authors:  R Blackstock; A Casadevall
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

4.  Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis.

Authors:  R Blackstock; N C Hernandez
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance.

Authors:  R Blackstock; J M McCormack; N K Hall
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Immunosuppression in experimental cryptococcosis in rats: modification of macrophage functions by T suppressor cells. Macrophages functions in cryptococcosis.

Authors:  H R Rubinstein; C E Sotomayor; L A Cervi; C M Riera; D T Masih
Journal:  Mycopathologia       Date:  1989-10       Impact factor: 2.574

Review 7.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

Review 8.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

9.  Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.

Authors:  R L Mosley; J W Murphy; R A Cox
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

10.  Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.

Authors:  S Mukherjee; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.